Annual report

Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 146
MetricValuePeriodScopeSource row
Revenue¥6.3bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥6.1bn2023-01-01 → 2023-12-31Cons.Net sales
Revenue¥5.0bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Revenue¥11.3bn2021-01-01 → 2021-12-31dCons.Net sales (5-year summary)
Revenue¥17.6bn2020-01-01 → 2020-12-31dCons.Net sales (5-year summary)
Operating income¥629m2024-01-01 → 2024-12-31Cons.Operating income
Operating income−¥1.0bn2023-01-01 → 2023-12-31Cons.Operating income
Ordinary income¥688m2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31Cons.Ordinary income
Ordinary income−¥3.4bn2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income−¥6.1bn2021-01-01 → 2021-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥5.5bn2020-01-01 → 2020-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥565m2024-01-01 → 2024-12-31Cons.Income before income taxes
Profit before tax−¥3.6bn2023-01-01 → 2023-12-31Cons.Income before income taxes
Net income (owners)¥898m2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥3.6bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)−¥4.9bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥9.6bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.9bn2020-01-01 → 2020-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥898m2024-01-01 → 2024-12-31Cons.Profit loss
Net income−¥3.6bn2023-01-01 → 2023-12-31Cons.Profit loss
Total assets¥12.9bnat 2024-12-31Cons.Assets
Total assets¥13.2bnat 2023-12-31Cons.Assets
Total assets¥15.0bnat 2022-12-31dCons.Total assets (5-year summary)
Total assets¥22.5bnat 2021-12-31dCons.Total assets (5-year summary)
Total assets¥31.8bnat 2020-12-31dCons.Total assets (5-year summary)
Total liabilities¥4.9bnat 2024-12-31Cons.Liabilities
Total liabilities¥6.5bnat 2023-12-31Cons.Liabilities
Net assets / equity¥8.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥8.0bnat 2022-12-31dCons.Net assets
Net assets / equity¥12.8bnat 2021-12-31dCons.Net assets (5-year summary)
Net assets / equity¥22.8bnat 2020-12-31dCons.Net assets (5-year summary)
Cash and deposits¥4.5bnat 2024-12-31Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥4.5bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥5.2bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2022-12-31dCons.Cash and cash equivalents
Cash & equivalents¥5.5bnat 2021-12-31dCons.Cash and cash equivalents (5-year summary)
Cash & equivalents¥4.7bnat 2020-12-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow¥362m2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥307m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥2.0bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.6bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.5bn2020-01-01 → 2020-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥5m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥1.2bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow¥190m2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.6bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥2.8bn2020-01-01 → 2020-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow−¥1.2bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥1.5bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥997m2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥4.0bn2021-01-01 → 2021-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥649m2020-01-01 → 2020-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥17.92024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-76.252023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-112.262022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-220.522021-01-01 → 2021-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥89.182020-01-01 → 2020-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.822020-01-01 → 2020-12-31dCons.Diluted earnings per share (5-year summary)
Net assets per share¥158.67at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥134.93at 2023-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥184.6at 2022-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥293.88at 2021-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥525.83at 2020-12-31dCons.Net assets per share (5-year summary)
Equity ratio61.7%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio53.5%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio56.8%at 2021-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio71.7%at 2020-12-31dCons.Equity to asset ratio (5-year summary)
ROE12.2%2024-01-01 → 2024-12-31Cons.Rate of return on equity (5-year summary)
ROE-48.9%2023-01-01 → 2023-12-31Cons.Rate of return on equity (5-year summary)
ROE-47.0%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
ROE-53.9%2021-01-01 → 2021-12-31dCons.Rate of return on equity (5-year summary)
ROE18.3%2020-01-01 → 2020-12-31dCons.Rate of return on equity (5-year summary)
Employees214at 2024-12-31Cons.Number of employees
Employees208at 2023-12-31Cons.Number of employees
Employees210at 2022-12-31dCons.Number of employees
Employees264at 2021-12-31dCons.Number of employees
Employees274at 2020-12-31dCons.Number of employees
Revenue¥5.5bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.4bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥4.6bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥10.6bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥17.1bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥501m2024-01-01 → 2024-12-31StandaloneOperating income
Operating income−¥1.0bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥947m2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income−¥1.3bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income−¥3.3bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥5.9bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥5.5bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥829m2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax−¥3.7bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥1.2bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income−¥3.7bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income−¥5.0bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income−¥9.3bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.9bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥12.1bnat 2024-12-31StandaloneAssets
Total assets¥12.2bnat 2023-12-31StandaloneAssets
Total assets¥14.3bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥21.9bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥31.0bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥4.7bnat 2024-12-31StandaloneLiabilities
Total liabilities¥6.2bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥7.4bnat 2024-12-31StandaloneNet assets
Net assets / equity¥6.0bnat 2023-12-31StandaloneNet assets
Net assets / equity¥7.5bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥12.4bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥22.2bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥3.5bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥4.1bnat 2023-12-31StandaloneCash and deposits
EPS (basic)¥23.342024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-78.632023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-113.642022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-213.032021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥89.572020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥89.212020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥252020-01-01 → 2020-12-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥147.67at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥120.52at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥171.91at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥284.83at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥512.14at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio61.1%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio49.1%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio52.4%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio56.6%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio71.6%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE17.4%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE-55.1%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE-49.8%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE-53.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE18.9%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued50,636,900at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued50,436,900at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued44,136,900at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued44,136,900at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued44,001,900at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees186at 2024-12-31StandaloneNumber of employees
Employees178at 2023-12-31StandaloneNumber of employees
Employees175at 2022-12-31dStandaloneNumber of employees
Employees226at 2021-12-31dStandaloneNumber of employees
Employees237at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 58
SegmentItemPeriodValue
Otherother segmentsrevenue2024-01-01 → 2024-12-31¥5m
Otherother segmentsrevenue external2024-01-01 → 2024-12-31¥5m
Otherother segmentssegment assetsat 2024-12-31¥13m
Otherother segmentssegment profit2024-01-01 → 2024-12-31−¥12m
Reconciling Itemsreconcilingcapex2024-01-01 → 2024-12-31¥67m
Reconciling Itemsreconcilingdepreciation2024-01-01 → 2024-12-31¥24m
Reconciling Itemsreconcilingsegment assetsat 2024-12-31¥5.8bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥837m
Infection Control Businessreportable segmentcapex2024-01-01 → 2024-12-31¥4m
Infection Control Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥12m
Infection Control Businessreportable segmentemployeesat 2024-12-3144 pure
Infection Control Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥508m
Infection Control Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥508m
Infection Control Businessreportable segmentsegment assetsat 2024-12-31¥710m
Infection Control Businessreportable segmentsegment profit2024-01-01 → 2024-12-31−¥467m
Pharmaceuticals Businessreportable segmentcapex2024-01-01 → 2024-12-31¥137m
Pharmaceuticals Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥220m
Pharmaceuticals Businessreportable segmentemployeesat 2024-12-31143 pure
Pharmaceuticals Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentsegment assetsat 2024-12-31¥6.3bn
Pharmaceuticals Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥1.9bn
—segment totalemployeesat 2024-12-31187 pure
Total Of Reportable Segments And Otherssegment totalcapex2024-01-01 → 2024-12-31¥142m
Total Of Reportable Segments And Otherssegment totaldepreciation2024-01-01 → 2024-12-31¥232m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-12-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-12-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-12-31¥7.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-12-31¥1.5bn
Otherother segmentsrevenue2023-01-01 → 2023-12-31¥5m
Otherother segmentsrevenue external2023-01-01 → 2023-12-31¥5m
Otherother segmentssegment assetsat 2023-12-31¥12m
Otherother segmentssegment profit2023-01-01 → 2023-12-31−¥28m
Reconciling Itemsreconcilingcapex2023-01-01 → 2023-12-31¥68m
Reconciling Itemsreconcilingdepreciation2023-01-01 → 2023-12-31¥135m
Reconciling Itemsreconcilingsegment assetsat 2023-12-31¥6.5bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-12-31−¥996m
Infection Control Businessreportable segmentcapex2023-01-01 → 2023-12-31¥89m
Infection Control Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥44m
Infection Control Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥929m
Infection Control Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥929m
Infection Control Businessreportable segmentsegment assetsat 2023-12-31¥823m
Infection Control Businessreportable segmentsegment profit2023-01-01 → 2023-12-31−¥1.2bn
Pharmaceuticals Businessreportable segmentcapex2023-01-01 → 2023-12-31¥101m
Pharmaceuticals Businessreportable segmentdepreciation2023-01-01 → 2023-12-31¥525m
Pharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥5.2bn
Pharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥5.2bn
Pharmaceuticals Businessreportable segmentsegment assetsat 2023-12-31¥5.8bn
Pharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥1.2bn
Total Of Reportable Segments And Otherssegment totalcapex2023-01-01 → 2023-12-31¥190m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-01-01 → 2023-12-31¥569m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-12-31¥6.1bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-12-31¥6.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-12-31−¥8m
Infection Control Businessreportable segmentemployeesat 2024-12-3137 pure
Pharmaceuticals Businessreportable segmentemployeesat 2024-12-31122 pure
—segment totalemployeesat 2024-12-31159 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,550
ItemContextValueUnit
Whether issuer of aforementioned shares holds reporting companys shares details of specified investment shares held for purposes other than pure investment reporting companyCurrentYearInstant_Row1Member
Original text (Japanese)無
Regulations in accordance with which consolidated financial statements have been prepared financial informationCurrentYearDurationText · Plus
Regulations in accordance with which financial statements have been prepared financial informationCurrentYearDurationText · Plus
Description of fact that financial statements have been prepared in accordance with special provision financial informationCurrentYearDuration
Original text (Japanese)  また、当社は、特例財務諸表提出会社に該当し、財務諸表等規則第127条の規定により財務諸表を作成しております。
Note on independent audit financial informationCurrentYearDurationText · Plus
Remarkable efforts to ensure fair presentation of consolidated financial statements etc financial informationCurrentYearDurationText · Plus
Consolidated balance sheet (text)CurrentYearDurationText · Plus
Consolidated statement of income (text)CurrentYearDurationText · Plus
Consolidated statement of comprehensive income (text)CurrentYearDurationText · Plus
Consolidated statement of changes in equity (text)CurrentYearDurationText · Plus
Consolidated statement of cash flows (text)CurrentYearDurationText · Plus
Notes significant accounting policies for preparation of consolidated financial statements (text)CurrentYearDurationText · Plus
Number of consolidated subsidiaries and names of major consolidated subsidiaries (text)CurrentYearDurationText · Plus
Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text)CurrentYearDurationText · Plus
Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text)CurrentYearDurationText · Plus
Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text)CurrentYearDurationText · Plus
Disclosure about fiscal years etc of consolidated subsidiaries (text)CurrentYearDurationText · Plus
Disclosure of accounting policies (text)CurrentYearDurationText · Plus
Significant accounting estimates consolidated financial statements (text)CurrentYearDurationText · Plus
Notes new accounting standards not yet applied consolidated financial statements (text)CurrentYearDurationText · Plus
Notes changes in presentation consolidated financial statements (text)CurrentYearDurationText · Plus
Notes regarding accumulated depreciation of property plant and equipment (text)CurrentYearInstantText · Plus
Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text)CurrentYearInstantText · Plus
Notes regarding pledged assets (text)CurrentYearInstantText · Plus
Notes regarding promissory notes due on balance sheet date (text)CurrentYearInstantText · Plus
Notes regarding amounts of notes and accounts receivable trade and contract assets (text)CurrentYearInstantText · Plus
Debtors notes regarding overdraft contracts and or loan commitments (text)CurrentYearInstantText · Plus
Notes regarding amount of revenue from contracts with customers (text)CurrentYearDurationText · Plus
Notes regarding write downs of inventories (text)CurrentYearDurationText · Plus
Major components of selling general and administrative expenses (text)CurrentYearDurationText · Plus
Research and development expenses included in general and administrative expenses and manufacturing cost for current period (text)CurrentYearDurationText · Plus
Notes regarding gain on sales of property plant and equipment (text)CurrentYearDurationText · Plus
Notes regarding loss on sales of property plant and equipment (text)CurrentYearDurationText · Plus
Notes regarding loss on disposal of property plant and equipment (text)CurrentYearDurationText · Plus
Notes regarding impairment loss (text)CurrentYearDurationText · Plus
Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text)CurrentYearDurationText · Plus
Notes regarding issued shares and treasury shares (text)Prior1YearDurationText · Plus
Notes regarding new share subscription rights etc (text)Prior1YearDurationText · Plus
Notes regarding dividend (text)Prior1YearDurationText · Plus
Notes regarding issued shares and treasury shares (text)CurrentYearDurationText · Plus
Notes regarding new share subscription rights etc (text)CurrentYearDurationText · Plus
Notes regarding dividend (text)CurrentYearDurationText · Plus
Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text)CurrentYearDurationText · Plus
Notes leases consolidated financial statements (text)CurrentYearDurationText · Plus
Notes financial instruments consolidated financial statements (text)CurrentYearDurationText · Plus
Notes securities consolidated financial statements (text)CurrentYearDurationText · Plus
Notes derivatives consolidated financial statements (text)CurrentYearDurationText · Plus
Notes retirement benefits consolidated financial statements (text)CurrentYearDurationText · Plus
Notes tax effect accounting consolidated financial statements (text)CurrentYearDurationText · Plus
Notes revenue recognition consolidated financial statements (text)CurrentYearDurationText · Plus

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass